Bhargava Phytolab Profile
Key Indicators
- Authorised Capital ₹ 1.32 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.32 Cr
as on 24-10-2024
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.33 Cr
as on 24-10-2024
- Revenue 13.73%
(FY 2023)
- Profit -127.52%
(FY 2023)
- Ebitda -32.02%
(FY 2023)
- Net Worth -1.19%
(FY 2023)
- Total Assets 8.96%
(FY 2023)
About Bhargava Phytolab
The Corporate was formerly known as R.S. Bhargava Pharmacy Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.32 Cr and a paid-up capital of Rs 1.32 Cr.
The company currently has active open charges totaling ₹6.33 Cr.
Kalpana Bhargava, Rajeshwar Bhargava, and Karan Bhargava serve as directors at the Company.
- CIN/LLPIN
U74899DL2001PTC109392
- Company No.
109392
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bhargava Phytolab?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshwar Bhargava  | Director | 25-Jan-2001 | Current |
| Karan Bhargava | Director | 01-Nov-2002 | Current |
| Kalpana Bhargava | Director | 25-Jan-2001 | Current |
Financial Performance of Bhargava Phytolab.
Bhargava Phytolab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.73% increase. The company also saw a substantial fall in profitability, with a 127.52% decrease in profit. The company's net worth dipped by a decrease of 1.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhargava Phytolab?
In 2023, Bhargava Phytolab had a promoter holding of 84.97% and a public holding of 15.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
212 Healthcare Private LimitedActive 3 years 13 daysKalpana Bhargava and Karan Bhargava are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Apr 2023 | ₹1.80 M | Open |
Axis Bank Limited Creation Date: 22 Sep 2022 | ₹3.20 M | Open |
Hdfc Bank Limited Creation Date: 24 May 2022 | ₹1.44 M | Open |
How Many Employees Work at Bhargava Phytolab?
Bhargava Phytolab has a workforce of 346 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhargava Phytolab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhargava Phytolab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
